Open AccessTc99m-MDP uptake in ascitic fluid in a patient with prostate carcinoma: A clue to detect metastases
Author(s) -
Debesh Chakraborty,
Manohar Kuruva,
Koramadai Karuppuswamy Kamleshwaran,
Anish Bhattacharya,
Baljinder Singh,
Bhagwant Rai Mittal
Publication year - 2011
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.104003
Subject(s) - medicine , bone scintigraphy , prostate cancer , abdomen , scintigraphy , prostate carcinoma , radiology , nuclear medicine , prostate , cancer
Bone scintigraphy with Tc-99m methylene diphosphonate (MDP) is used to detect metastases in patients with cancer. Uptake in non-osseous, non-urologic tissues is occasionally found in the routine bone scintigraphy, which may mimic as metastatic lesions. The authors describe the case of a 70-year-old man with prostate cancer, showing diffuse tracer uptake in the left hemithorax and entire abdomen on bone scan that required additional imaging modality for localization. Careful interpretation is needed of the unusual uptake of radiotracer in regions other than the skeleton for metastatic work up.